François Moisan

Enhancement of paclitaxel and carboplatin therapies by CCL2 blockade in ovarian cancers

François Moisan, E. Brian Francisco, Anamaria Brozović et al. · Molecular Oncology · 2014 · 115 citations · Full text

Decreased levels of baseline and drug-induced tubulin polymerisation are hallmarks of resistance to taxanes in ovarian cancer cells and are associated with epithelial-to-mesenchymal transition

George E. Durán, Yan C. Wang, François Moisan et al. · British Journal of Cancer · 2017 · 47 citations · Full text

Critical role of Aquaporin-1 and telocytes in infantile hemangioma response to propranolol beta blockade

François Moisan, Sandra Ouchérif, Priscilla Kaulanjan‐Checkmodine et al. · Proceedings of the National Academy of Sciences · 2021 · 38 citations · Full text

Relationships Between Genetic Polymorphisms and Anticancer Drug Cytotoxicity <i>Vis-à-Vis</i> the NCI-60 Panel

Valérie Le Morvan, Ricardo Bellott, François Moisan et al. · Pharmacogenomics · 2006 · 34 citations

UVB-induced DHODH upregulation, which is driven by STAT3, is a promising target for chemoprevention and combination therapy of photocarcinogenesis

Mohsen Hosseini, L. Dousset, P Michon et al. · Oncogenesis · 2019 · 24 citations · Full text